510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

Triage BNP Test for the Beckman Coulter Immunoassay Systems, Model Catalog #98200

K033383510(k) TraditionalCleared Dec 23, 200361-day reviewClass II21 CFR 862.1117Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biosite Incorporated · NBC Test, Natriuretic Peptide

Cleared on Dec 23, 2003 after a 61-day review. The FDA summary names its predicate without a number. 5 later devices descend from it. It has been recalled once.

Decided
Dec 23, 2003
Review
61 days
Class
Class II
Product code
NBC
Recalls
1
Predicates
0

5 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2006: 1 descendant cleared2026: 1 descendant cleared2014: 1 descendant cleared2011: 1 descendant cleared200020052010201520202025
  1. This deviceK033383 Triage BNP Test for the Beckman Coulter Immunoassay Systems, Model…Biosite Incorporated · 2003
  2. Descendant · cites it directly · 4 of its ownK052789 Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 2006 · Recalled
  3. Descendant · cites it directly · 2 of its ownK093758 BGM Galectin -3Bg Medicine, Inc. · 2010
  4. Descendant · 2 generations on · 0 of its ownK252169 Access BNP IIBeckman Coulter, Inc. · 2026
  5. Descendant · 2 generations on · 0 of its ownK140436 ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS…Fujirebio Diagnostics,Inc. · 2014
  6. Descendant · 2 generations on · 0 of its ownK111452 Presage ST2 AssayCritical Care Diagnostics, Inc. (Dba Critical Diag · 2011 · Recalled

Most influential descendants

Showing 5 of 5 · See all
  • K052789Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 2006 · cites it directly4descendants
  • K093758BGM Galectin -3Bg Medicine, Inc. · 2010 · cites it directly2descendants
  • K252169Access BNP IIBeckman Coulter, Inc. · 2026 · 2 generations on0descendants
  • K140436ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT GALECTIN-3…Fujirebio Diagnostics,Inc. · 2014 · 2 generations on0descendants
  • K111452Presage ST2 AssayCritical Care Diagnostics, Inc. (Dba Critical Diag · 2011 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K033383Triage BNP Test for the Beckman Coulter Immunoassay Systems, Model Catalog…Biosite Incorporated2003—
+1K052789Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated20061
+1K093758BGM Galectin -3Bg Medicine, Inc.2010—
+2K252169Access BNP IIBeckman Coulter, Inc.2026—
+2K140436ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT…Fujirebio Diagnostics,Inc.2014—
+2K111452Presage ST2 AssayCritical Care Diagnostics, Inc. (Dba Critical Diag20111

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
201010
201110
201410
202610
FIG. 1 — Lineage of K033383, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBC device

  1. #1 K262109 Access NT-proBNPscore 13.9 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Biosite Triage BNP test
Named without a submission number
—

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K052789Triage BNP Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated20064
K093758BGM Galectin -3Bg Medicine, Inc.20102

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 1, 2020Class IIZ-0297-2021Process controlProduct compromised during shipment.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K052789 (Biosite Incorporated, 2006) has gone furthest, with 4 descendants of its own.

How does its category compare?

All NBC devices

NBC Test, Natriuretic Peptide: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NBC

1in 2025

2007: 22008: 72010: 12020: 12021: 22022: 12023: 22024: 12025: 12026 (partial year): 4
2007high 7 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBC

126in 2008

2008: 126 days median2026 (partial year): 94 days median
2007high 126 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBC

1in 2020

2010: 12012: 22014: 12015: 12018: 12020: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NBC

17in 2025

2007: 172008: 152009: 352010: 612011: 532012: 232013: 132014: 702015: 432016: 312017: 92018: 72019: 92020: 62022: 42023: 262024: 142025: 17
2007high 70 (2014) · low 0 (2021)2025

MAUDE reports naming product code NBC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—017
20087126015
20090—035
20101—161
20110—053
20120—223
20130—013
20140—170
20150—143
20160—031
20170—09
20180—17
20190—09
20201—16
20212—00
20221—04
20232—026
20241—014
20251—017
20264940—

What is it indicated for?

The Triage® BNP test is intended for use with the Beckman Coulter Immunoassay Systems (Access, Access 2, Synchron LXi 725, and UniCel Dxl 800) for the in vitro quantitative measurement of B-Type Natriuretic Peptide (BNP) in plasma specimens using EDTA as the anticoagulant. The test is used as an aid in the diagnosis and assessment of severity of congestive heart failure. The test also is used for the risk stratification of patients with acute coronary syndromes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K033383: Triage BNP Test for the Beckman Coulter Immunoassay Systems, Model Catalog #98200.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K033383

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026